期刊文献+

澳大利亚的经验对我国基本药物目录遴选的启示 被引量:18

Impression of Australian Experiences to the Selection of Chinese Essential Drug List
下载PDF
导出
摘要 优化国家基本药物的遴选途径和方法,完善国家基本药物制度。介绍了澳大利亚基本药物目录的发展过程、管理机构及遴选情况,以期为我国的基本药物目录遴选提供借鉴。精简优化《国家基本药物目录》,将有利于公众获得基本药物。 The approach and methods for the selection of national essential drugs were optimized and the national essential drug system was improved. The selection of Australian essential drug list was introduced. It would be helpful to study the selection of essential drug list in China. Simplifying national essential drug list can facilitate people's access to essential drugs.
出处 《中国药事》 CAS 2008年第11期961-963,968,共4页 Chinese Pharmaceutical Affairs
关键词 澳大利亚 国家基本药物 基本药物目录 遴选 借鉴 Australia national essential drug essential drug list selcction guidance
  • 相关文献

参考文献6

  • 1Amanda Biggs. The Pharmaceutical Benefits Scheme? an Ovcrview[EB/OL].[2004-01-06]. http://www. aph. gov.au/library/INTGUIDE/SP/pbs. htm # development. Updated.
  • 2Significant dates in the history of the Pharmaceutical Benefits Scheme [EB/OL]. [2006-05-26]. http: //www. vcp. monash, edu. au/departments/pharrnpract/pharmace/ legislation.html. Updated.
  • 3武瑞雪,刘宝,丁敬芳,陈璐,王峦,叶露.基本药物制度实施的国际经验[J].中国药房,2007,18(17):1283-1285. 被引量:35
  • 4How medicine is subsidised and listed through the PBS [EB/ OL]. [2008-04-17]. http: //www. medicare_australia gov. au/provider/pubs/mediguide/section7/pbs-subsidy. jsp # N10087. Updated.
  • 5龚向光,胡善联.澳大利亚药物经济学评价指南介绍[J].卫生经济研究,2002,19(6):21-23. 被引量:13
  • 6孟锐,李颖.国家基本药物遴选与药物经济学[J].中国药房,2007,18(35):2721-2723. 被引量:27

二级参考文献7

共引文献71

同被引文献120

引证文献18

二级引证文献97

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部